PRESS RELEASE published on 09/30/2025 at 14:01, 9 months 14 days ago Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting Mainz Biomed to present innovative colorectal cancer screening approach at WEO CRC Meeting. Dr. Lena Krammes will discuss RNA-based diagnostics findings for early cancer detection and prevention Mainz Biomed Colorectal Cancer Screening RNA-based Diagnostics WEO CRC Meeting
PRESS RELEASE published on 09/30/2025 at 14:00, 9 months 14 days ago Avemio Group Improves Earnings and Significantly Expands Digital Business in the First Half of 2025 Avemio Group achieves earnings improvement and expands digital business significantly in the first half of 2025, with revenue from digital business rising and efficiency program underway Revenue Growth Digital Business Earnings Improvement Efficiency Program Avemio Group
PRESS RELEASE published on 09/30/2025 at 14:00, 9 months 14 days ago Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV Bausch Health's Solta Medical to feature Thermage FLX, Clear + Brilliant, and Fraxel FTX on The Balancing Act. Innovative treatments for youthful appearance showcased on Lifetime TV Thermage FLX Bausch Health Fraxel FTX Solta Medical Clear + Brilliant
PRESS RELEASE published on 09/30/2025 at 14:00, 9 months 14 days ago Tokenwell Launches Retail Crypto Investing App in the United States Tokenwell launches retail crypto investing app on App Store and Google Play, providing professionally designed crypto baskets to U.S. investors. Germany to follow as first European market Retail Investors European Expansion App Launch Tokenwell Crypto Baskets
PRESS RELEASE published on 09/30/2025 at 14:00, 9 months 14 days ago Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies Wellgistics Health partners with TheracosBio to improve affordability and access to diabetes medication Brenzavvy in the U.S. healthcare system through their maker-to-taker platform and network of 6,500+ pharmacies TheracosBio BRENZAVVY Pharmaceutical Distribution Wellgistics Health Diabetes Medication
PRESS RELEASE published on 09/30/2025 at 13:54, 9 months 14 days ago United Labels reports on the first half of the year and expects positive development for 2025 as a whole United Labels AG reports on the first half of 2025, reflecting a decline in revenue due to order shifts but anticipates growth for the full year. The company's online business saw a 6% sales increase Financial Report Sales Growth Online Business United Labels AG First Half 2025
PRESS RELEASE published on 09/30/2025 at 13:44, 9 months 14 days ago VVV Sports Limited: Interim Results for the six months ended 30 June 2025 VVV Sports Limited announces unaudited interim results for the six months to 30 June 2025. Focus shifts from mineral exploration to sports and media investment sector. Completed a capital raise of £1,000,000 to support new direction Financial Review Capital Raise Interim Results Sports Investment VVV SPORTS LIMITED
PRESS RELEASE published on 09/30/2025 at 13:35, 9 months 14 days ago Atlas Salt Announces Updated Feasibility Study with Enhanced Results for the Great Atlantic Salt Project; $920M Post-Tax NPV8 and 21.3% Post-Tax IRR Atlas Salt Inc. announces results of Updated Feasibility Study for Great Atlantic Salt Project, projecting strong financial outlook and operational efficiency Operational Efficiency Atlas Salt Inc. Great Atlantic Salt Project Financial Outlook Updated Feasibility Study
PRESS RELEASE published on 09/30/2025 at 13:30, 9 months 14 days ago MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction MIRA Pharmaceuticals completes acquisition of SKNY Pharmaceuticals, strengthening financial position. SKNY-1 for obesity and smoking cessation, Ketamir-2 for neuropathic pain, and MIRA-55 for inflammatory pain Acquisition Pipeline Therapeutics MIRA Pharmaceuticals SKNY Pharmaceuticals
PRESS RELEASE published on 09/30/2025 at 13:22, 9 months 14 days ago E-Cite Motors Executes Stock Lockup Agreement Eliminating 90% of Potential Conversions, Strengthening Capital Structure and Protecting Shareholders E-Cite Motors' largest investor commits to one-year lockup, safeguarding shareholder value and ensuring long-term growth. Regulatory advantage propels company ahead of traditional OEMs Electric Vehicles Investor E-Cite Motors Lockup Agreement Regulatory Advantage
Published on 07/15/2026 at 02:00, 5 hours 38 minutes ago Global Education Communities Corp. Reports F2026 Q3 Financial Results
Published on 07/15/2026 at 01:45, 5 hours 53 minutes ago Ur-Energy Appoints US Energy and Mining Veteran as Chair of the Board
Published on 07/14/2026 at 22:30, 9 hours 8 minutes ago Hillcrest Energy Technologies Announces Board and Leadership Changes Following 2026 Annual General Meeting
Published on 07/14/2026 at 22:30, 9 hours 8 minutes ago Loop Industries Reports First Quarter Fiscal 2027 Results and Provides Update on Progress Towards Commercialization
Published on 07/15/2026 at 07:11, 27 minutes ago Heidelberg Pharma Reports on First Half-Year 2026 and the Positive Course of Business
Published on 07/15/2026 at 07:00, 38 minutes ago FRIEDRICH VORWERK secures major contract as part of a joint venture (ARGE) to build the H2Coastlink 1 hydrogen pipeline from Emden to Leer
Published on 07/15/2026 at 07:00, 38 minutes ago DocMorris reports strong revenue growth of 15% in the second quarter; Rx grows by 46% and Digital Services by 80%
Published on 07/15/2026 at 07:00, 38 minutes ago Kontron Transportation receives major order worth nearly 100 million euro
Published on 07/13/2026 at 18:00, 1 day 13 hours ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 07:30, 2 days ago Disclosure of transactions in own shares from July 6 to July 10, 2026
Published on 07/10/2026 at 18:00, 4 days 13 hours ago Half-year liquidity contract statement for CEGEDIM